(3alpha,5beta)-3-Hydroxy-7,12-dioxocholan-24-oic acid(CAS: 517-33-9)

The regulatory guidelines for (3alpha,5beta)-3-Hydroxy-7,12-dioxocholan-24-oic acid (CAS: 517-33-9) include GHS classification under the Globally Harmonized System of Classification and Labelling of Chemicals, REACH regulations for European Union member states, and FDA/EPA requirements for its use in pharmaceutical and industrial applications. Proper handling, storage, and disposal practices must comply with these regulations to ensure safety and environmental protection.

Several alternatives to (3alpha,5beta)-3-Hydroxy-7,12-dioxocholan-24-oic acid can be used in synthesis based on the specific application. Commonly, isomers and analogs such as 3-oxocholan-24-oic acid can be considered. Other substitute reagents like ursodeoxycholic acid are also viable options depending on the desired chemical properties and reaction conditions.

The market and research trends for (3alpha,5beta)-3-Hydroxy-7,12-dioxocholan-24-oic acid (CAS: 517-33-9) are showing growth in pharmaceutical and biotechnological applications. Research is focusing on its potential as an anti-inflammatory and hepatoprotective agent. Market trends indicate increasing demand due to its unique chemical properties and potential therapeutic uses. However, precise price trends and demand levels may fluctuate based on industry dynamics.

Waste containing (3alpha,5beta)-3-Hydroxy-7,12-dioxocholan-24-oic acid (CAS: 517-33-9) should be handled with care to ensure safety and environmental protection. Collection should be done in appropriate containers, and the waste should be incinerated or disposed of by a professional waste disposal service. Environmental precautions include minimizing spillage during handling and ensuring that any contaminated materials are properly contained to prevent soil or water pollution. Compliance with local and national regulations is essential.